Last deal

$15M

Amount

Series B

Stage

01.08.2005

Date

3

all rounds

$15M

Total amount

General

About Company
Protez Pharmaceuticals develops and sells antibiotics for difficult hospital infections.

Industry

Sector :

Subsector :

Keywords :

founded date

01.04.2003

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Founded in 2003 by Christopher M. Cashman, Protez Pharmaceuticals is a medical research company based in Malvern, Pennsylvania. They specialize in creating intravenous and oral small molecule antibiotics to combat bacterial resistance and treat chronic or recurrent infections commonly found in hospitals.
Contacts